Download PDF
Dtsch Med Wochenschr 2008; 133: S253-S256
DOI: 10.1055/s-0028-1100956
Übersicht | Review article
Kardiologie, Hypertensiologie
© Georg Thieme Verlag KG Stuttgart · New York

Epidemiologie des Hochdruckherzens

Epidemiology of the hypertensive heartM. Middeke1
  • 1Hypertoniezentrum München
Further Information

Publication History

eingereicht: 11.2.2008

akzeptiert: 23.10.2008

Publication Date:
15 December 2008 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

Hochdruckherz - Linksventrikuläre Hypertrophie

Keywords

hypertensive heart disease - left ventricular hypertrophy

Literatur

  • 1 Beckett N S, Peters R, Fletcher A E. et al, for the HYVET Study Group . Treatment of Hypertension in Patients 80 Years of Age or Older.  N Engl J Med. 2008;  358 1887-98
    Search in Google Scholar
  • 2 Casale P N, Devereux R B, Milner M. et al . Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men.  Ann Intern Med. 1986;  105 173-178
    Search in Google Scholar
  • 3 Coca A, Gabriel R, de la Figuera M. et al . The impact of different echocardiographic diagnostic criteria on the prevalence of the left ventricular hypertrophy in essential hypertension: the VITAE study.  J Hypertens. 1999;  17 1471-1480
    Search in Google Scholar
  • 4 Dahlöf B, Devereux R B, Kjeldsen S E. et al . Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.  Lancet. 2002;  359 995-1003
    Search in Google Scholar
  • 5 Devereux R B, Casale P N, Kligfield P. et al . Performance of primary and derived M-mode echocardiographic measurements for detection of left ventricular hypertrophy in necropsied subjects and in patients with systemic hypertension, mitral regurgitation and dilated cardiomyopathy.  Am J Cardiol. 1986;  57 (15) 1388-93
    Search in Google Scholar
  • 6 Franz I W, Tönnesmann U, Müller J F. Time course of complete normalization of left ventricular hypertrophy during long-term antihypertensive therapy with angiotensin converting enzyme inhibitors.  Am J Hypertens. 1998;  1 631-9
    Search in Google Scholar
  • 7 Gottdiener J S, Brown J, Zoltick J, Fletcher R D. Left ventricular hypertrophy in men with normal blood pressure: relation to exaggerated blood pressure response to exercise.  Ann Intern Med. 1990;  112 (3) 161-66
    Search in Google Scholar
  • 8 Guidelines: 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).  J Hypertens. 2007;  25 1105-1187
    Search in Google Scholar
  • 9 Hammond I W, Devereux R B, Alderman M H. et al . The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension.  J Am Coll Cardiol. 1986;  7 639-650
    Search in Google Scholar
  • 10 Ikeda. et al . Morning rise in blood pressure associates with hypertensive cardiovascular complications.  J Hypertens. 2002;  20 (Suppl 4) S150
    Search in Google Scholar
  • 11 Jung J. Vorhofflimmern als Endpunkt bei Studien zur arteriellen Hypertonie.  Dtsch Med Wochenschr. 2003;  129 2493-46
    Search in Google Scholar
  • 12 Kannel W B, Gordon T, Offutt T. Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study.  Ann Intern Med. 1969;  71 (1) 89-105
    Search in Google Scholar
  • 13 Kannel W B. Left ventricular hypertrophy as a risk factor in arterial hypertension.  Eur Heart J. 1992;  13 (Suppl D) 82-88
    Search in Google Scholar
  • 14 Klingbeil A U, Schneider M, Martus P, Messerli F H, Schmieder R E. et al . A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension.  Am J Med. 2003;  115 41
    Search in Google Scholar
  • 15 Lauer M S, Levy D, Anderson K M, Plehn J F. Is there a relationship between exercise systolic blood pressure response and left ventricular mass? The Framingham Heart Study.  Ann Intern Med. 1992;  116 (3) 203-10
    Search in Google Scholar
  • 16 Levy D, Anderson K M, Savage D D. et al . Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors.  Ann Intern Med. 1988;  108 7-13
    Search in Google Scholar
  • 17 Levy D. Clinical significance of left ventricular hypertrophy: insights from the Framingham Study.  J Cardiovasc Pharmcol. 1991;  17 Suppl 2 S1-6
    Search in Google Scholar
  • 18 Lindholm L H, Carlberg B, Samuelsson O. Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis.  Lancet. 2005;  366 (9496) 1545-53
    Search in Google Scholar
  • 19 Lopez A D, Mathers C D, Ezzati M. et al . Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data.  Lancet. 2006;  367 1747-57
    Search in Google Scholar
  • 20 MacMahon S, Peto R, Cutler J. et al . Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias.  Lancet. 1990;  335 765-74
    Search in Google Scholar
  • 21 Mancia G, Zanchetti A, Agabiti-Rosei E. et al . Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation.  Circulation. 1997;  95 1464-1470
    Search in Google Scholar
  • 22 Matsuo. et al . Morning rise in blood pressure is a risk factor for cardiovascular complications in treated hypertensive patients.  J Hypertens. 2002;  20 (Suppl 4) S314
    Search in Google Scholar
  • 23 Meisinger C, Heier M, Völzke H. Regional disparities of hypertension prevalence and management within Germanyet al.  Journal of Hypertension. 2006;  24 293-299
    Search in Google Scholar
  • 24 Middeke M. Hypertensiologie 2007.  Dtsch Med Wochenschr. 2007;  132 1368-72
    Search in Google Scholar
  • 25 Middeke M. Praxismormotonie. In: Middeke Arterielle Hypertonie. Stuttgart New York; Georg Thieme Verlag 2005
    Search in Google Scholar
  • 26 Mosterd A, D’Agostino R B, Silbershatz H. Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 – 1989.  N Engl J Med. 1999;  340 1221-27
    Search in Google Scholar
  • 27 Motz W, Vogt M, Rabenau O, Scheler S, Lückhoff A, Strauer B E. Evidence of endothelial dysfunction in coronary resistance vessels in patients with angina pectoris and normal coronary angiograms.  Am J Cardiol. 1991;  68 (10) 996-03
    Search in Google Scholar
  • 28 Motz W, Scheler S, Strauer B E. Coronary microangiopathy in hypertensive heart disease: pathogenesis, diagnosis and therapy.  Herz. 1995;  33 901-09
    Search in Google Scholar
  • 29 Muiesan M L, Salvetti M, Rizzoni D. et al . Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment.  J Hypertens. 1995;  13 1091-1095
    Search in Google Scholar
  • 30 Norman J E. Improved detection of echocrdiographic left ventricular hypertrophy using a new electrocardiographic algorithm.  J Am Coll Cardiol. 1993;  21 1680-86
    Search in Google Scholar
  • 31 Ott C, Schwarz T, Hilgers K F. et al . Left-ventricular structure and function are influenced by angiotensinogen gene polymorphism (-20 A/C) in young male patients.  Am J Hypertens. 2007;  20 (9) 974-80
    Search in Google Scholar
  • 32 Ott C, Titze S I, Schwarz T K. et al . High sodium intake modulates left ventricular mass in patients with G expression of + 1675 G/A angiotensin II receptor type 2 gene.  J Hypertens. 2007;  25 (8) 1627-32
    Search in Google Scholar
  • 33 Plehn G, Schwartzkopff B. Gestörte Dehnbarkeit des Hochdruckherzens unter Belastung als früher Marker einer diastolischen Dysfunktion.  Dtsch Med Wochenschr. 2005;  130 568-73
    Search in Google Scholar
  • 34 Savage D D, Drayer J I, Henry W L. et al . Echocardiographic assessment of cardiac anatomy and function in hypertensive subjects.  Circulation. 1979;  59 623-632
    Search in Google Scholar
  • 35 Schillaci G, Verdecchia P, Porcellati C. et al . Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension.  ypertension. 2000;  35 580-586
    Search in Google Scholar
  • 36 Schirmer H, Lunde P, Rasmussen K. Prevalence of left ventricular hypertrophy in general population; The Tromso Study.  Eur Heart J. 1999;  20 429-38
    Search in Google Scholar
  • 37 Schmieder R E, Langenfeld M R, Friedrich A. et al . Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension.  Circulation. 1996;  94 1304-1309
    Search in Google Scholar
  • 38 Schwartzkopff B, Motz W, Frenzel H, Vogt M, Knauer S, Strauer B E. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension.  Circulation. 1993;  88 993-03
    Search in Google Scholar
  • 39 Sokolow M, Lyon T P. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads.  Am Heart J. 1949;  37 (2) 161-86
    Search in Google Scholar
  • 40 Strauer B E. Das Hochdruckherz. Pathophysiologie-Diagnostik-Therapie. Berlin; Springer-Verlag 1983: 1-184
    Search in Google Scholar
  • 41 Strauer B E. Ventricular function and coronary hemodynamics in hypertensive heart disease.  Am J Cardiol. 1979;  44 999-06
    Search in Google Scholar
  • 42 UK Prospective Diabetes Study Group . Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 39.  BMJ. 1998;  317 713-20 und 703 – 13
    Search in Google Scholar
  • 43 Vakili B A, Okin P M, Devereux R B. Prognostic implications of left ventricular hypertrophy.  Am Heart J. 2001;  141 334-341
    Search in Google Scholar
  • 44 Vaudo G, Schillaci G, Evangelista F. et al . Arterial wall thickening at different sites and its association with left ventricular hypertrophy in newly diagnosed essential hypertension.  Am J Hypertens. 2000;  13 324-31
    Search in Google Scholar
  • 45 Verdecchia P, Schillaci G, Borgioni C. et al . Prognostic significance of serial changes in left ventricular mass in essential hypertension.  Circulation. 1998;  97 48-54
    Search in Google Scholar
  • 46 Verdecchia P, Reboldi G, Gattobigio R. et al . Atrial fibrillation in hypertension: predictors and outcome.  ypertension. 2003;  41 218-223
    Search in Google Scholar
  • 47 Walenta K, Böhm M. Hypertensive Koronaropathie.  Dtsch Med Wochenschr. 2003;  129 2476-78
    Search in Google Scholar

Prof. Dr. med. Martin Middeke

Hypertoniezentrum München

Dienerstr. 12

80331 München

Email: info@blutdruckinstitut.de

URL: http://www.hypertoniezentrum.de